Welcome!

On behalf of the Organizing Committee, I would like to cordially invite you to participate in the 12th WCBP Symposium, which will be held January 28-30, 2008 at the Renaissance Mayflower Hotel in Washington DC. Similar to past WCBP meetings, this Symposium will be organized by CASSS and co-sponsored by the US FDA.

At the Symposium, you will hear several plenary sessions addressing scientific and regulatory issues on topics such as Regulation of Biopharmaceutical Products, Quality Risk Management, Advances in Analytical & Product Platforms for Vaccine Development, Application of DOE in the Creation of Design Space, Analytical Challenges for Personalized Therapeutics, Implementing Process Control Strategies During Manufacturing as well as New & Emerging Analytical Technologies and Non-mammalian Eukaryotic Expression for Biologics. In keeping with the goal of the Symposium to provide a forum for discussion, all plenary sessions will be followed by several workshops which provide a venue for continued interaction between industry, CDER and CBER colleagues. We invite you to participate in the lively discussions during the three days with industry and FDA colleagues.

Siddharth J. Advant, Tunnell Consulting
Symposium Co-Chair